In this episode of Global Equity Research, David Mitchell and Emily Carter unpack the explosive rise of Czechoslovak Group (CSG) from a Czech private industrial group into one of Europe’s most valuable pure-play defense companies.

Drawing on proprietary research from Softgate Capital Research, they walk through CSG’s record-breaking 2026 IPO, its dominant position in global ammunition markets, and its rapidly expanding footprint in land systems, defense electronics, and aerospace propulsion. The discussion explores how CSG is leveraged to Europe’s multi-year defense spending supercycle, backed by a €14 billion backlog and sector-leading margins.

David and Emily break down the hypergrowth financials, the balance sheet and M&A strategy behind CSG’s scale-up, and how the company stacks up against peers like Rheinmetall, BAE Systems, and Saab. They also tackle key risks—from Ukraine exposure and high defense concentration to governance and execution—and outline the main catalysts that could drive the stock toward a €40 price target.

Listeners come away with a concise, data-driven view of whether CSG represents a compelling way to gain exposure to Europe’s defense renaissance.

Explore ArcelorMittal's transformation into a structurally improved, cycle‑leveraged steel giant poised for recovery. This episode dives into the company's scale, strategic pillars like decarbonization, financial journey, and disciplined capital allocation shaping its growth in the evolving global market.

Explore Roche's strategic dual-pillar model and how its pharmaceutical and diagnostics businesses fuel a robust recovery. Uncover scientific innovations shaping its future pipeline and key financial metrics that signal durable growth and investment potential.